Press Releases

As Feds Probe Pharma’s Middlemen, Capital Rx Raises $106 Million For Software-Driven Fix

August 3, 2022

Capital Rx

The Federal Trade Commission took aim at the prescription drug middlemen known as pharmacy benefit managers last week, announcing an inquiry into the opaque system of rebates, claw backs and other financial wizardry that determines how much patients end up paying at the pharmacy counter. The timing couldn’t be better for AJ Loiacono, the cofounder and CEO of Capital Rx, who has spent the past five years building price transparency and claims processing software for this moment. Read the Forbes article here.

DOWNLOAD NOWBack to Insights

Sign up for our newsletter!

Get the latest information on JUDI news, webinars, and industry insights through our newsletter. Sign up now!